At Creative Biolabs, we are focused on our clients, and passionate about our role in providing the most valuable solutions to maximize the success of our clients. We have developed a series of solutions to support your cellular and gene therapy product candidates, including one-stop CAR-T therapy, TCR-T therapy, etc. To overcome the obstacles presented by immunosuppressive tumor microenvironment, we developed virus specific T cell (VST) technology to build more effective T cells.
Virus Specific T Cell (VST) Technology
Our born immune system can provide protection from viral infection that exists or may exist in the future. Virus specific T cells (VSTs) are critical for providing protection against many types of viruses which could potentially cause disease. These cells have the capability of infected cells’ recognition and killing, which is coordinated by other parts of immune system. VSTs persist in the infection environment and activate a rapid immune response once encountering viral antigens. Here are processes of VSTs treatment to kill viral infected cells.
VST technology shows clinical safety and efficacy in treating solid tumor, and VSTs can overcome key limitations faced by other traditional T cell therapies.
How VST can be Involved in Your Project
Creative Biolabs offers CAR-VST development to enhance safety, durability, and persistence compared with conventional CAR-T cells. We provide a wide range of CARs to recognize various cancer types.
Creative Biolabs offers our clients with the combinational therapy - oncolytic viruses and VSTs to boost the innate and adaptive immune response against cancers.
If you have any other interests in VST technology such as combination with checkpoint inhibitor, etc., please contact us for more discussions.
We are proud to partner with our clients on their journey of novel therapy innovations. Creative Biolabs is committed to offering the most comprehensive, integrated portfolio to facilitate your drug development. If you have any interests in our solutions or techniques, please don’t hesitate to contact us to learn how we can be involved in your project.
For any technical issues or products/services related questions, please leave your contacts as below, and our team will contact you at earliest convenience to let you know how we can be involved in your projects.
Nanoparticle Tiny Tech for Programming T Cells: A novel technology to increase the efficiency and value of your CAR-T therapy project.LEARN MORE
End-to-end CAR Hybrid TCR (CHyT)-T Cell Therapy Development Services: A novel solution to engineer T cell to be a promising cellular therapy product with the complete TCR complex without HLA matching dependence.LEARN MORE
TRAC-CAR-T Cell Development with CRISPR/Cas9 Technology: A novel technology to build more powerful CAR-T cells.LEARN MORE